8/15/24 17:12 | 8/13/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | M.d | 1,038 | 73.60 | 0 | 14 | 81 | 32 | D | | | | | | | | | | | | | | |
8/15/24 17:12 | 8/13/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | S.d | -2,120 | 150.38 | 0 | -14 | -31 | 32 | D | | | | | | | | | | | | | | |
7/18/24 16:45 | 7/16/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | M.d | 66 | 73.60 | 0 | 1 | 3 | 32 | D | | | | | | | | | | | | | | |
7/18/24 16:45 | 7/16/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | S.d | -135 | 150.04 | 0 | -1 | -3 | 32 | D | | | | | | | | | | | | | | |
5/16/24 16:40 | 5/14/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | M.dm | 2,208 | 73.60 | 0 | 30 | 999% | 32 | D | | | | | | | | | | | | | | |
5/16/24 16:40 | 5/14/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | S.dm | -4,138 | 137.95 | 0 | -30 | -49 | 32 | D | | | | | | | | | | | | | | |
2/15/24 17:27 | 2/13/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | S.d | -180 | 132.85 | 0 | -1 | -4 | 32 | D | | | | | | | | | | | | | | |
2/8/24 19:12 | 2/6/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | S.m | -314 | 138.73 | 0 | -2 | -7 | 30 | D | | | | | | | | | | | | | | |
2/2/24 19:00 | 1/31/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | S | -181 | 140.72 | 0 | -1 | -4 | 28 | D | | | | | | | | | | | | | | |
8/23/23 19:58 | 8/21/23 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | S | -229 | 107.39 | 0 | -2 | -7 | 27 | D | | | | | | | | | | | | | | |
2/8/23 19:16 | 2/6/23 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | S.m | -2,933 | 102.61 | 0 | -29 | -53 | 25 | D | | | | | | | | | | | | | | |
2/2/23 16:53 | 1/31/23 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | S | -141 | 109.98 | 0 | -1 | -6 | 21 | D | | | | | | | | | | | | | | |